Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Not all eicosanoids are bad.

Thea Morris1, Ravindra Rajakariar, Melanie Stables

  • 1Centre for Clinical Pharmacology and Therapeutics, Division of Medicine, 5 University Street, University College London, London WC1E 6JJ, UK.

Trends in Pharmacological Sciences
|October 24, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L-Glutamine attenuates peritoneal fibrosis developed in 5-Fluorouracil-treated mice.

Experimental biology and medicine (Maywood, N.J.)·2026
Same author

POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following <i>in vivo</i> LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study.

Frontiers in immunology·2026
Same author

Challenges of monocyte HLA-DR targeted immunomodulation in sepsis-a prospective observational cohort study.

Frontiers in immunology·2026
Same author

Epoxy-oxylipins direct monocyte fate in inflammatory resolution in humans.

Nature communications·2026
Same author

Real world use of belimumab in patients with lupus nephritis.

Lupus·2025
Same author

Sharing regional capacity in deceased donor kidney transplantation: experience from a regional collaborative in a metropolitan area.

Clinical kidney journal·2025
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
Same journal

Biosensors for translatable GPCR bias.

Trends in pharmacological sciences·2026
Same journal

ECM stiffness and epigenetics in organ fibrosis.

Trends in pharmacological sciences·2026
See all related articles

Lipoxins act as an internal "handbrake" by activating suppressors of cytokine signaling. This research highlights endogenous mechanisms that control inflammation and suggests new drug targets for inflammatory diseases.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Inflammation is a critical immune response, but its dysregulation contributes to various diseases.
  • Understanding the endogenous mechanisms that resolve inflammation is crucial for therapeutic development.

Purpose of the Study:

  • To identify key components of the body's internal anti-inflammatory mechanisms.
  • To investigate the role of lipoxins in regulating inflammatory responses.

Main Methods:

  • The study focused on the molecular pathways involved in inflammation resolution.
  • Researchers examined how lipoxins interact with suppressors of cytokine signaling.

Main Results:

  • Lipoxins were found to activate suppressors of cytokine signaling (SOCS).

Related Experiment Videos

  • This activation effectively dampens inflammatory responses, particularly to infection.

    • Conclusions:

    • Lipoxins are essential components of the endogenous 'handbrake' that controls inflammation.
    • This discovery opens avenues for novel drug development targeting lipoxin pathways for anti-inflammatory therapies.